> From: dsummersmi...@comcast.net <dsummersmi...@comcast.net>

<Me> 
> >OK, so I'm still harping on lifestyle as preferable over drugs in 
> treating and preventing chronic illnesses -- nice to have my
> opinion backed up so decisively!  

> I'd be curious to see if the lifestyle and weight loss
> group continued to include follow ups of all the failures. 

From the WebMD article (cited last post):
"...Many of the people in the lifestyle intervention group met the weight loss 
goal, losing an average of 15 pounds during the first year of the study.  While 
they regained, on average, 10 of those pounds during the next seven years, the 
lifestyle intervention group continued to have the lowest rates of diabetes..."

If you're defining 'failure' as regain of weight, they still benefitted WRT 
diabetes prevention/delay of onset.

This is from the Lancet abstract:
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(09)61457-4/abstract

"...All active DPP participants were eligible for continued follow-up. 2766 of 
3150 (88%) enrolled for a median additional follow-up of 5·7 years (IQR 
5·5—5·8). 910 participants were from the lifestyle, 924 from the metformin, and 
932 were from the original placebo groups. On the basis of the benefits from 
the intensive lifestyle intervention in the DPP, all three groups were offered 
group-implemented lifestyle intervention. Metformin treatment was continued in 
the original metformin group (850 mg twice daily as tolerated), with 
participants unmasked to assignment, and the original lifestyle intervention 
group was offered additional lifestyle support..."

I think 88% continuance of original participants is pretty good.

"...During the 10·0-year (IQR 9·0—10·5) follow-up since randomisation to DPP, 
the original lifestyle group lost, then partly regained weight. The modest 
weight loss with metformin was maintained..."

- and yet their diabetes rate was still lower than the metformin subset.

Commentary from another journal:
http://www.medicalnewstoday.com/articles/169082.php

"...The authors explain: "In this study, onset of diabetes was delayed by about 
4 years by lifestyle intervention and 2 years by metformin compared with 
placebo." 

They write in conclusion: "Our results have shown that a reduction in diabetes 
cumulative incidence by either lifestyle intervention or metformin therapy 
persists for at least 10 years. Further follow-up will provide crucial data for 
long-term clinical outcomes, including mortality... The long-term reductions in 
bodyweight and diabetes are encouraging, but further quantification of 
long-term outcomes is crucial to establish the benefits of diabetes 
prevention..." 

> You know of course, that weight
> loss programs that do not involve surgery have about a 3%
> sucess rate after 2 years....

What made this study noteworthy to me was that *in spite of* regaining much of 
the weight lost, delay of diabetes onset still was better than the drug (or of 
course no intervention at all).  Also, surgery results for extreme obesity are 
much better than mild or overweight (further confusion with use of BMI vs. 
'ideal weight,' follow-up years, and changes in surgical techniques (some 
studies are based on out-moded procedures).  This 2006 Mayo article was one of 
the better ones I found:

http://www.mayoclinicproceedings.com/content/81/10_Suppl/S46.full

"... Few randomized, controlled prospective trials have compared bariatric 
surgery to nonsurgical weight-loss treatments, and the quality of current 
outcome data is suboptimal. However, the available evidence suggests that 
bariatric surgery, and particularly gastric bypass, is the most effective 
weight-loss treatment for people with extreme (class III) obesity. In addition 
to reduced energy intake and to a lesser extent malabsorption, numerous other 
potential mechanisms related to bariatric surgery may play a role in promoting 
weight loss and improving comorbidities. After bariatric surgery, clinical 
improvement or resolution has been reported in 64% to 100% of patients with 
diabetes mellitus, 62% to 69% of patients with hypertension, 85% of patients 
with obstructive sleep apnea, 60% to 100% of patients with dyslipidemia, and up 
to 90% of patients with nonalcoholic fatty liver disease. A wide range of other 
weight-related conditions also appear to
 improve, and limited data suggest that overall mortality may decrease in 
patients undergoing bariatric surgery. Although not conclusive, evidence from 
available studies indicates that bariatric surgery is cost-effective. Further 
research with improved methodology is needed to define the mechanisms of action 
of bariatric surgery; to document its effect on long-term weight loss, comorbid 
conditions, and overall mortality; and to determine its cost-effectiveness...

"With the exception of 2 studies published more than 20 years ago and 2 studies 
published in 2002 and 2006, no other prospective randomized controlled trials 
have compared bariatric surgery with nonsurgical approaches. The first 2 trials 
compared either jejunoileal bypass or horizontal gastroplasty (surgical 
procedures no longer performed) to medical treatment. The study by Mingrone et 
al compared outcomes in a diet group with those in a group undergoing a 
biliopancreatic diversion (BPD) procedure. After 1 year, men and women in the 
diet group lost an average of 6.2% and 5.8% of initial body weight, 
respectively, compared with an average loss of 34.3% and 28%, respectively, in 
the BPD group. In the study by O'Brien et al, 80 adults with mild to moderate 
obesity (body mass index [calculated as weight in kilograms divided by the 
square of height in meters], 30-35 kg/m2) were randomized to an intensive 
medical program vs placement of a laparoscopic
 adjustable gastric band (LAGB). At 2 years, mean weight loss in the medical 
and surgical groups was 5.5% and 21.6%, respectively..."


> ...That's why my wife's physician strongly reccomended this
> surgery for her...

I have myself recommended surgery for a few select patients -- but the study I 
originally cited was about lifestyle changes vs. drug or nothing, and outcome 
was in delay/prevention of disease, not only weight loss.


Debbi
Experiencing Massive Carb-craving With Shorter Days Maru  :P


      

_______________________________________________
http://mccmedia.com/mailman/listinfo/brin-l_mccmedia.com

Reply via email to